Open original FDA record ↗Recall record
- FDA identifier
- Z-2880-2026
- Company in FDA record
- Siemens Healthcare Diagnostics, Inc.
- FDA classification date
- Aug 4, 2026
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class III
Reason stated in the source
Out-of-specification sodium azide concentration in Syva Emit Disopyramide Enzyme Immunoassay Calibrator Lot U1. While the assay results were not impacted, the overall health risk to lab technicians due to this issue is low, as exposure is limited by small volumes and a 0.2% post-reconstitution sodium azide concentration, with the worst outcome being mild skin or eye irritation and no serious harm anticipated.
Source facts
- Action
- On 6/26/2026, Siemens issued Urgent Medical Device Correction letters to all affected customers informing them of the issue and providing instructions. Customers are instructed to refer to the SDS which were created and provided with the Urgent Medical Device Corrections and the Urgent Field Safety Notices specifically for Syva Emit Disopyramide Assay Lot U1 for information regarding handling and disposal.
- Initiated
- 2026-06-26
- Root cause
- Under Investigation by firm
- Distribution
- Worldwide - US Nationwide distribution in the states of CA and VA. The country of Japan.
- Recall number
- Z-2880-2026
- Recall status
- Open, Classified
- CDRH record ID
- 221446
- FDA classified
- 2026-08-04
- Recall event number
- 99379